published Jul 10th 2017, 5:18 pm, by Anna Edney (Bloomberg) —Congress must renew a fee program that funds government review of new drugs and medical devices, but a legislative logjam over the Senate’s health-care overhaul stands in its way. Lawmakers need to sign off on the drug and device fees

published Aug 29th 2016, 12:16 pm, by Megan McArdle (Bloomberg View) — The last few weeks have featured a great deal of news for Obamacare, most of it bad. Insurers are pulling out of the exchanges and premiums are rising. Coverage has been expanded, but it increasingly looks as if

published Jun 16th 2016, 3:58 pm, by Noah Feldman (Bloomberg View) — The Supreme Court is supposed to take appellate cases to make the law clearer. Today’s opinion on health-care fraud had the opposite effect. Instead of spelling out exactly when a misrepresentation in health-care billing counts as a legal